Novel Insights into RAS-ERK Signaling Pathways in Pediatric Malignancies
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: closed (15 September 2023) | Viewed by 217
Special Issue Editors
Interests: NF1; RAS signaling; MPNST; rhabdomyosarcoma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are excited to have the opportunity to organize a Special Issue dedicated to novel insights into RAS-ERK signaling pathways in pediatric malignancies in the journal Cells (impact factor 7.67). This Special Issue will highlight the most recent research conducted in the field of ERK signaling and will emphasize basic original science, as well as invited review articles.
We would like to invite you to submit either an original research or review article to this Special Issue, in recognition of your contribution to the field. Our primary focus in this edition will be RAS and ERK signaling pathways, biologic insights, targeted therapy applications, and clinical trial results in pediatric solid tumors and hematologic malignancies. This Special Issue will also focus on genomic methods being developed and applied to advance our understanding of these tumors and the application of potential therapeutic strategies. We aim to emphasize how genomic knowledge can translate to advances in the management of patients affected by these tumors.
Dr. Christine A. Pratilas
Dr. Angelina V. Vaseva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ERK signaling
- targeted therapy
- pediatric solid tumor